from Reuters: Health News https://reut.rs/2A84yNZ
Abbvie settles Humira patent disputes with Novartis unit
By
Abbvie Inc said on Thursday it settled all patent disputes with Novartis AG, granting it a non-exclusive license to manufacture and sell a copycat version of blockbuster drug, Humira.
from Reuters: Health News https://reut.rs/2A84yNZ
from Reuters: Health News https://reut.rs/2A84yNZ
Like This Post? Please share!
0 comments:
Post a Comment